Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Similar
Filing Names

Inserm institut National De La Sante Et De La Recherche Medicale
Inserm institut National De La Sante Et De La Recherche Medicale Institut Pasteur And
Inserm institut National De La Sante Et De La Recherche Medicale_20100107
Inserm institut National De La Sante Et De La Recherche Medicale_20100121
Inserm institut National De La Sante Et De La Recherche Medicale_20100128
Inserm institut National De La Sante Et De La Recherche Medicale_20100114
  

Inserm institut National De La Sante Et De La Recherche Medicale patents

Recent patent applications related to Inserm institut National De La Sante Et De La Recherche Medicale. Inserm institut National De La Sante Et De La Recherche Medicale is listed as an Agent/Assignee. Note: Inserm institut National De La Sante Et De La Recherche Medicale may have other listings under different names/spellings. We're not affiliated with Inserm institut National De La Sante Et De La Recherche Medicale, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "I" | Inserm institut National De La Sante Et De La Recherche Medicale-related inventors




Date Inserm institut National De La Sante Et De La Recherche Medicale patents (updated weekly) - BOOKMARK this page
11/16/17 new patent  Vibrotactile stimulation device
11/16/17 new patent  Vibrotactile stimulation device
11/16/17 new patent  Treatment of acute exacerbations of chronic obstructive pulmonary disease by antagonism of the il-20r
11/09/17Methods and pharmaceutical compositions using orexins (oxa, oxb) for the treatment of prostate cancers
11/09/17Cyclic antimicrobial pseudopeptides and uses thereof
11/09/17Methods of diagnosing cancer and of predicting response of cancer to dendrogenin a treatment
11/02/17Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity
11/02/17Polypeptides for the treatment of angiogenesis or lymphangiogenesis-related diseases
10/19/17Automated analyzing and interpreting an antimicrobial susceptibility
09/28/17Pharmaceutical compositions for preventing glucocorticoid-induced corneal or skin thinning
09/28/17Antibodies directed against icos for treating graft-versus-host disease
09/21/17Methods and pharmaceutical compositions for treatment of cystic fibrosis
09/14/17Combined use of a trka inhibitor and an epha2 inhibitor for using in the treatment of solid cancers, and the prognosis of survival of a patient who has a solid cancer
09/14/17Methods for detecting inactivation of the homologous recombination pathway (brca1/2) in human tumors
08/31/17Fluorinated pyridazin-3-ones for the use thereof in the treatment of lung diseases
08/31/17Methods and pharmaceutical compositions for the treatment of erythropoietic protoporphyria
08/17/17Antibodies directed against icos and uses thereof
08/10/173-(4'-substituted)-benzyl-ether derivatives of pregnenolone
08/03/17Anti-neurotensin long fragment antibodies and uses thereof
08/03/17Human soluble cd146, preparation and uses thereof
07/27/17Methods for treating neuromuscular junction-related diseases
07/27/172-oxo-3,4-dihydropyridine-5-carboxylates and their use
07/20/17Pharmaceutical compositions comprising agonists of orexin-1 receptor ox1r for the treatment of inflammatory bowel diseases
07/06/17Method for producing methane by means of aerobic co-culture of anaerobic micro-organisms
06/29/17Methods and compositions for treating neuropathic pain
06/29/17Use of uric acid for culturing bacteria sensitive to oxygen tension
06/29/17Methods and compositions for treating neuropathic pain
06/29/17Methods for determining whether a patient will achieve a response after radiation therapy
06/22/17Methods for selecting binders by phage display and masked selection
06/22/17Method and pharmaceutical composition for use in the treatment of neurodegenerative disorders
06/22/17Methods for determining the oncogenic condition of cell, uses thereof, and methods for treating cancer
06/15/17Methods and pharmaceutical compositions for the treatment of cardiovascular fibrosis
05/25/17Use of mcoln-1 modulators to regulate cell migration
05/18/17Derivatives of 2h-pyrazolo[4,3-c]quinolin-3(5h)-one and use thereof
05/11/17Inhibitors of the pp1/gadd34 complex for the treatment of a condition requiring an immunosuppressive activity
05/11/17Methods and compositions for diagnosing, monitoring and treating cancer
04/27/17Polypeptides as apelin inhibitors and uses thereof
03/09/17Methods for preventing and treating chronic kidney disease (ckd)
03/09/17Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
02/23/17Methods and pharmaceutical compositions for the cardioprotection
02/23/17Methods and pharmaceutical compositions for treating vaso-occlusive crisis
02/23/17Methods and pharmaceutical compositions for the treatment of diseases mediated by the nrp-1/obr complex signaling pathway
02/23/17Methods for diagnosing and treating iron dysregulation
02/16/17Polypeptides and uses thereof for reducing cd95-mediated cell motility
02/16/17Methods for the treatment of leber congenital amaurosis
01/26/17Methods and pharmaceutical compositions for the treatment of beta-thalassemias
01/19/17Ulipristal acetate for prevention and treatment of breast tumors
12/22/16Methods for diagnosing and treating myhre syndrome
12/15/16Biomarkers of mineralocorticoid receptor activation
11/24/16Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating e. coli induced inflammatory bowel diseases such as crohn's disease
11/17/16Novel antigen peptide and uses thereof
11/10/16Methods for adhering tissue surfaces and materials and biomedical uses thereof
11/03/16Hdl comprising a therapeutic agent and use in therapy
10/27/16Methods and pharmaceutical compositions for expressing a polynucleotide of interest in the retinal pigment epithelium of a subjece
10/20/16Ddr1 antagonist or an inhibitor of ddr1 gene expression for use in the prevention or treatment of crescentic glomerulonephritis
10/13/16Aqueous solution for preserving an organ and uses during hypothermic ischemia
10/13/16Methods and pharmaceutical compositions for treatment of cystic fibrosis
10/13/16Compositions and methods for treatment of movement disorders
09/29/16Crosslinked polysaccharide beads and their biomedical uses
09/22/16Kits-of-parts comprising nucleic acids able to form a kissing complex and their uses thereof
09/15/16Antibodies directed against icos and uses thereof
08/04/16Method for characterising an ultrasound wound in organic tissues
08/04/16Method of treating haemophilia by inducing tolerance to blood factors
07/28/16Methods and compositions for treatment of retinal degenerative diseases
07/21/16Compositions and methods for inducing senescence in cancer cells
Patent Packs
07/14/16Methods for selecting competent oocytes and competent embryos with high potential for pregnancy outcome
06/30/16Anti-claudin 1 antibodies and uses thereof
06/16/16Methods for predicting and treating bone metastases in prostate cancer patients
06/09/16Method and medium for neural differentiation of pluripotent cells
06/02/16Biomarkers, methods and kits for the diagnosis of rheumatoid arthritis
05/26/16Antagonists of cb1 receptor
05/26/16Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof
05/19/16Pharmaceutical compositions for preventing glucocorticoid-induced corneal or skin thinning
05/19/16Antibodies against human cd39 and use thereof for inhibiting t regulatory cells activity
04/21/16Modulators of intracellular chloride concentration for treating neurodegenerative diseases with parkinsonian syndromes
03/24/16Production of antibody formats and immunological applications of said formats
03/17/16Method for preparing viral particles with cyclic dinucleotide and use of said particles for inducing immune response
02/11/16Method and pharmaceutical composition for use in the treatment of cancer
02/04/16Methods and pharmaceuticals compositions for treating breast cancers
02/04/16Method for diagnosing or predicting a non syndromic autosomal recessive optic atrophy, or a risk of a non syndromic autosomal recessive optic atrophy
Patent Packs
01/28/16Methods for the treatment and the prognostic assessment of malignant pleural mesothelioma
01/28/16Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure
12/10/15Methods and pharmaceutical composition for the preservation of vascular endothelial cell barrier integrity
12/03/15Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
11/26/15Matrix metalloproteinase 9 (mmp-9) aptamer and uses thereof
10/22/15Methods for the treatment and diagnosis of atherosclerosis
10/08/153-(4'-substituted)-benzyl-ether derivatives of pregnenolone
09/17/15Cluster of differentiation 36 (cd36) as a therapeutic target for hiv infection
09/03/15Method for preparing porous scaffold for tissue engineering
08/27/15Antibodies directed against hepatitis c virus e1e2 complex, compositions of hcv particles, and pharmaceutical compositions
08/27/15Antibodies directed against icos for treating graft-versus-host disease
08/13/15Bioprinting station, assembly comprising such bioprinting station and bioprinting method
08/06/15Tif1-gamma for treating and diagnosing inflammatory diseases
08/06/15Methods and kits for screening patients with a cancer
08/06/15Diagnostic of heart failure
07/30/15Multimeric mannosides, a process for preparing the same and their uses as a drug
07/30/15Glycan compositions, processes for preparing the same and their uses as a drug
07/23/15Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes
07/16/15Use of transferrin receptor antagonist for the treatment of thalassemia
07/09/15Methods for determining whether a cytomegalovirus infection in a transplanted patient is suceptible to induce allograft rejection
07/02/15Methods and pharmaceutical compositions for treatment of cystic fibrosis
07/02/15Methods for preventing and treating chronic kidney disease (ckd)
06/25/15Chitosan hydrogel for repairing nerve tissue
06/25/15Methods for predicting whether a subject is at risk of developing a follicular lymphoma
06/18/15Gene mutations for the diagnosis of arthrogryposis multiplex congenita and congenital peripheral neuropathies disease
06/18/15Marker peptides for determining the occurrence of an inflammatory state in a subject
06/18/15Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension
06/11/15Protozoan variant-specific surface proteins (vsp) as carriers for oral drug delivery
06/04/15Method for quantifying immune cells in tumoral tissues and its applications
05/28/15Btla antibodies and uses thereof
Social Network Patent Pack
05/21/15Methods and pharmaceutical compositions for the treatment of pancreatic cancer
05/21/15Methods for diagnosing and treating focal segmental glomerulosclerosis
05/14/15Methods for the diagnosis and the treatment of familial thoracic aortic aneurysms caused by tgfb2 loss of function mutations
05/14/15Method for the diagnosis of early rheumatoid arthritis
05/14/15Novel melanoma antigen peptide and uses thereof
05/14/15Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
05/14/15Methods for the diagnosis and the treatment of familial thoracic aortic aneurysms caused by tgfb2 loss of function mutations
05/07/15Methods and pharmaceutical compositions for prevention or treatment of chronic obstructive pulmonary disease
05/07/15Method and pharmaceutical composition for use in the treatment and diagnotic of anemia of inflammation
05/07/15Method and pharmaceutical composition for use in the treatment of cancer
Patent Packs
05/07/15Inhibitors of the pp1/gadd34 complex for the treatment of a condition requiring an immunosuppressive activity
04/30/15Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
04/30/1528 kda gst proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a th1 and/or th17 response
04/23/15Methods for the treatment of leber congenital amaurosis
04/16/15Methods for selecting binders by phage display and masked selection
04/16/15Methods for the treatment and diagnosis of bone mineral density related diseases
04/16/15Methods and pharmaceutical compositions for prevention or treatment of ischemia related organ damage
04/16/15Method for diagnosing a skeletal ciliopathy
04/02/15Methods for the screening of antibacterial substances
03/26/15Cryopreservation of cells, tissues and organs
03/19/15Methods for observing cells with cell wall or invertebrate embryos with oblong eggshell
03/12/15Polypeptides as apelin inhibitors and uses thereof
03/05/15Crosslinked polysaccharide beads comprising an imaging agent
03/05/15Crosslinked polysaccharide beads comprising an imaging agent
02/26/15Compositions and methods for inihibiting tumorigenicity of senescent cancer cells induced by chemotherapy
02/26/15Microsphere compositions, preparation method and applications thereof
02/26/15Methods for the treatment of nonalcoholic steatohepatitis
02/19/15Method and pharmaceutical composition for use in the treatment or the prevention of aneurysm
02/12/15Devices and methods for observing eukaryotic cells without cell wall
02/05/15Methods and compositions for treatment of retinal degenerative diseases
01/15/15Anti-infective compounds
01/08/15Use of microrna molecules to influence skin pigmentation
01/01/15Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2
01/01/15Method for the prognosis of survival time of a patient suffering from a solid cancer
01/01/15Methods for the detection and the treatment of diastolic dysfunction
12/18/14Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation
12/18/14Methods for assessing endometrial receptivity of a patient after controlled ovarian hyperstimulation
12/04/14Reprogrammation of eukaryotic cells with engineered microvesicles
11/13/14Pd-1 antibodies and pd-l1 antibodies and uses thereof
10/02/14Methods for screening substances capable of modulating the replication of an influenza virus
Patent Packs
09/25/14Methods for predicting the response to anti-cancer treatment with an agonist of tlr7 or an agonist of tlr8
08/28/14Direct protein delivery with engineered microvesicles
08/07/14Polymer particles or nano-vectors and use thereof as a drug and/or diagnostic agent
08/07/14Methods for determining the oncogenic condition of cell, uses thereof, and methods for treating cancer
07/17/14Compositions and methods for inhibiting tumor development caused by chemotherapy induced senescence
07/03/14Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals
07/03/14Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
05/15/14Fucoidans as ligands for the diagnosis of degenerative pathologies
05/15/14Methods for adjusting expression of mitochondrial genome by microrna
05/08/14Method for expanding monocytes
05/01/14Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2
05/01/14Therapeutics for age-related macular degeneration
03/27/14Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
01/30/14Methods for diagnosing and treating iron dysregulation
07/25/13Anti-glycoprotein vi scfv fragment for treatment of thrombosis
07/11/13Methods and kits for the diagnosis of rheumatoid arthritis
05/23/13Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection
05/23/13Methods and compositions for the treatment of fluid accumulation in and/ or under the retina
05/16/13Anti-cd160 specific antibodies for the treatment of eye disorders based on neoangiogenesis
04/04/13Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
Social Network Patent Pack
12/20/12Direct protein delivery with engineered microvesicles
10/18/12Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
10/04/12Mitf as a marker for predisposition to cancer
09/27/12Neuronal viability factor and use thereof
09/06/12Spla2 iia polymorphism analysis for the diagnosis/prognosis of a cardiovascular disease/event
09/06/12Method and system for treatment of a body of a mammal in cardiac arrest
08/16/12Neurotensin analogues for radioisotope targeting to neurotensin receptor-positive tumors
08/16/12Labeled adenosine for use in positron emission tomography
07/19/12Fucoidans as ligands for the diagnosis of degenerative pathologies
07/12/12Hdl comprising a therapeutic agent and use in therapy
07/12/12Upregulation of integrin linked kinase (ilk) to provide cardioprotective effects
06/28/12Predicting the responsiveness of a patient to a treatment with an anti-cd20 antibody and a diagnosing rheumatoid arthritis
06/28/12Anaplerotic therapy of huntington disease and other polyglutamine diseases
04/19/12Fucoidans as ligands for the diagnosis of degenerative pathologies
03/15/12Serotonin 5-ht3 receptor antagonists for use in the treatment of lesional vestibular disorders
03/08/12Predicting the responsiveness to an anti-tnf alpha antibody treatment
01/05/12Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2
12/15/11Methods for treatment, the prognostic assessment and the detection of breast cancer
10/20/11Method for detecting soluble amyloid precursor protein (app) alpha and/or soluble app beta
09/29/11Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection
Social Network Patent Pack
09/08/11Inhibitors of mrp4 and agents stimulating mrp4 activity for the treatment of cardiac disorders
09/01/11Novel melanoma antigen peptide and uses thereof
07/28/11Transgenic animals and methods of making recombinant antibodies
06/09/11Treatment and prevention of dry age-related macular degeneration by activating cd36
05/05/11Natural killer p30 (nkp30) dysfunction and the biological applications thereof
03/24/11Methods for diagnosing and treating iron dysregulation
03/17/11Methods and kits for the diagnosis of rheumatoid arthritis
02/24/11Methods for the treatment, the prognostic assessment and the staging of non-small cell lung cancer
01/13/11Human specific escherichia coli strains
12/16/10Use of fzc18-containing collagen 18 polypeptides for the treatment, diagnosis and outcome prediction of diseases
11/11/10Methods for the treatment and diagnosis of bone mineral density related diseases
11/04/10Inhibitors of mrp4 for the treatment of vascular disorders
08/19/10Azapeptides as cd36 binding compounds
08/12/10In vitro beating heart model
08/05/10Method for predicting the outcome of a critically ill patient
08/05/10Antibody or fragment thereof recognizing avitagtm and uses thereof
08/05/10Method for culturing mammalian stem cells
07/22/10Anticonvulsive pharmaceutical compositions
06/03/10Method to produce light-emitting nano-particles of diamond
05/06/10Chirp reversal ultrasound contrast imaging
04/29/10Methods for diagnosing and treating graft rejection and inflammatory conditions
03/11/10Anticonvulsive pharmaceutical compositions
03/11/10Anaplerotic therapy of huntington disease and other polyglutamine diseases
01/28/10Methods for treating latent tuberculosis
01/21/10Compounds regulating calreticulin, kdel receptor and/or erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
01/14/10Use of soluble cd160 to suppress immunity
01/07/10Method for expanding monocytes
12/24/09Nucleic acids for expressing a polynucleotide of interest in mammalian cancer cells
12/17/09Methods for the screening of antibacterial substances
12/10/09Method for expressing polypeptides in eukaryotic cells using alternative splicing
Social Network Patent Pack
11/19/09Methods for analyzing differential gene expression associated with myeloproliferative disorders (mpd) cancer disease
11/12/09Device and the time-based analysis of the agitation of a bedridden patient
10/08/09Method for predicting responsiveness to tnf alpha blocking agents
08/27/09Vitro the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
07/09/09Polynucleotides encoding mhc class i-restricted htert epitopes, analogues thereof or polyepitopes
05/21/09Vitamin d derivatives active on the vitamin d nuclear receptor, preparation and uses thereof
01/28/10Methods for treating latent tuberculosis
01/21/10Compounds regulating calreticulin, kdel receptor and/or erp-57 cell surface exposure and uses thereof to evaluate the efficiency of a cancer treatment
01/14/10Use of soluble cd160 to suppress immunity
01/07/10Method for expanding monocytes
09/19/13Glycoconjugates and their use as potential vaccines against infection by shigella flexneri







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Inserm institut National De La Sante Et De La Recherche Medicale in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Inserm institut National De La Sante Et De La Recherche Medicale with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';